From: Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
Model 1 | Model 2 | Model 3 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Variable | HR | p value | 95% Confidence limits for HR | HR | p value | 95% Confidence limits for HR | HR | p value | 95% Confidence limits for HR | |||
Atorvastatin | ||||||||||||
Versus CV | 0.80 | 0.0005 | 0.71 | 0.91 | 0.90 | 0.09 | 0.79 | 1.02 | 0.91 | 0.11 | 0.80 | 1.02 |
Age | 1.11 | <0.0001 | 1.10 | 1.12 | 1.11 | <0.0001 | 1.10 | 1.11 | ||||
Hypertension | 1.10 | 0.0590 | 1.00 | 1.20 | ||||||||
CVD | 1.13 | 0.0005 | 1.05 | 1.20 | ||||||||
Diabetes | 1.12 | 0.0009 | 1.05 | 1.20 | ||||||||
Charlson Index | 1.78 | <0.0001 | 1.66 | 1.91 | ||||||||
Lovastatin | ||||||||||||
Versus CV | 0.98 | 0.70 | 0.89 | 1.08 | 0.95 | 0.32 | 0.86 | 1.05 | 0.95 | 0.34 | 0.86 | 1.05 |
Age | 1.11 | <0.0001 | 1.10 | 1.12 | 1.11 | <0.0001 | 1.10 | 1.11 | ||||
Hypertension | 1.09 | 0.07 | 0.99 | 1.19 | ||||||||
CVD | 1.12 | 0.0005 | 1.05 | 1.20 | ||||||||
Diabetes | 1.12 | 0.0009 | 1.05 | 1.20 | ||||||||
Charlson Index | 1.74 | <0.0001 | 1.62 | 1.86 | ||||||||
Simvastatin | ||||||||||||
Versus CV | 0.45 | <0.0001 | 0.43 | 0.47 | 0.45 | <0.0001 | 0.43 | 0.48 | 0.46 | <0.0001 | 0.44 | 0.48 |
Age | 1.11 | <0.0001 | 1.10 | 1.11 | 1.11 | <0.0001 | 1.10 | 1.11 | ||||
Hypertension | 1.07 | 0.07 | 1.00 | 1.15 | ||||||||
CVD | 1.09 | 0.0012 | 1.04 | 1.15 | ||||||||
Diabetes | 1.08 | 0.0034 | 1.03 | 1.14 | ||||||||
Charlson Index | 1.72 | <0.0001 | 1.63 | 1.81 |